The blockbuster weight loss drug Wegovy is now approved in the U.S. for heart health. But some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say ...
Many consumers have a gap in their homeowners insurance coverage. This puts them at financial risk, and they are likely ...
On December 16, Mizuho analyst Yaron Kinar initiated coverage of Prudential Financial, Inc. (NYSE:PRU) with a Neutral rating and a $125 price target. The initiation was part of a broader launch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results